Nanotherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference

ALACHUA, Fla.--()--Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that management will give a corporate presentation at the 28th Annual Piper Jaffray Healthcare Conference. Additional information is as follows:

Date:         Wednesday, November 30, 2016
Time: 2:30 pm ET
Location: Lotte New York Palace Hotel

About Nanotherapeutics, Inc.

Nanotherapeutics is a contract development and manufacturing organization (CDMO) that operates a U.S.-based 183,000 square foot, state of the art, single-use, multi-purpose-multi- product, BSL-3 capable facility offering clients extensive capabilities, including a pilot facility for performing optimization of upstream, downstream and formulation functions, bulk cGMP manufacturing, and analytical development for proteins, antibodies, viral vaccines and gene therapy drug products. The Company provides expertise from preclinical through FDA licensure in a variety of production platforms, including microbial and mammalian cell culture. The Company also owns a second, Czech Republic-based, 165,000 square foot, 6,000-liter capacity BSL-3 facility for manufacturing vaccines using its proprietary Vero cell platform. For more information, visit the Company website at www.nanotherapeutics.com.

Contacts

At Nanotherapeutics, Inc.
Gary Ascani, 386-418-8745
Vice President of Business Development
gascani@nanotherapeutics.com
or
At Rx Communications Group, LLC
Melody Carey, 917-322-2571
President
mcarey@rxir.com

Contacts

At Nanotherapeutics, Inc.
Gary Ascani, 386-418-8745
Vice President of Business Development
gascani@nanotherapeutics.com
or
At Rx Communications Group, LLC
Melody Carey, 917-322-2571
President
mcarey@rxir.com